Jamil Farshchi - 10 Feb 2026 Form 4 Insider Report for EQUIFAX INC (EFX)

Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
10 Feb 2026
Net transactions value
-$877,043
Form type
4
Filing time
12 Feb 2026, 16:08:08 UTC
Previous filing
28 Oct 2025
Next filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Farshchi Jamil EVP, Chief Technology Officer 1550 PEACHTREE STREET, N.W., ATLANTA /s/Lisa Stockard as Attorney-in-Fact 12 Feb 2026 0001732980

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $1,189,417 +6,213 +16% $191.44 45,624 10 Feb 2026 Direct F1, F2
transaction EFX Common Stock Award $0 +4,667 +10% $0.000000 50,291 10 Feb 2026 Direct F2
transaction EFX Common Stock Tax liability $616,644 -3,042 -6% $202.71 47,249 10 Feb 2026 Direct F2
transaction EFX Common Stock Sale $1,216,568 -6,213 -13% $195.81 41,036 10 Feb 2026 Direct F1, F2
transaction EFX Common Stock Sale $233,248 -1,167 -2.8% $199.87 39,869 11 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -6,213 -100% $0.000000 0 10 Feb 2026 Common Stock 6,213 $191.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
F3 The option vested in three equal annual increments beginning 2/21/2021.